Advertisement

 

 

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016.

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016.
Author Information (click to view)

Lagging M, Wejstål R, Norkrans G, Karlström O, Aleman S, Weiland O, Castedal M, Westin J, ,


Lagging M, Wejstål R, Norkrans G, Karlström O, Aleman S, Weiland O, Castedal M, Westin J, , (click to view)

Lagging M, Wejstål R, Norkrans G, Karlström O, Aleman S, Weiland O, Castedal M, Westin J, ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Infectious diseases (London, England) 2017 03 15() 1-15 doi 10.1080/23744235.2017.1300682

Abstract

In a recent expert meeting, Swedish recommendations for the treatment of hepatitis C virus (HCV) infection were updated. An interferon-free combination of direct-acting antiviral agents is considered and indicated for all patients with chronic HCV infection, but the ability to treat all is limited primarily by high cost of medication. The group of patients prioritized for therapeutic intervention has been extended to also include fertile women desiring to become pregnant. A more thorough discussion of treatment for people who inject drugs (PWIDs) in order to diminish transmission is included, and the clinical significance of baseline NS5A resistance associated variants (RAVs), also known as resistance associated substitutions (RASs), for the treatment of HCV genotype 1a or 3 infection is discussed.

Submit a Comment

Your email address will not be published. Required fields are marked *

eight + three =

[ HIDE/SHOW ]